Marco Di Carlo Selected Research

Marco Di Carlo Research Topics

Disease

17	Pain (Aches) 04/2024 - 01/2018
9	Fibromyalgia (Fibrositis) 06/2023 - 01/2020
9	Rheumatoid Arthritis 06/2022 - 12/2015
6	Arthritis (Polyarthritis) 10/2022 - 01/2015
5	Neuralgia (Stump Neuralgia) 06/2022 - 01/2020
4	Frailty 04/2023 - 05/2020
4	Inflammation (Inflammations) 04/2023 - 01/2020
3	Interstitial Lung Diseases (Interstitial Lung Disease) 06/2022 - 01/2016
3	Synovitis 04/2019 - 12/2017
3	Rheumatic Diseases (Rheumatism) 01/2019 - 11/2016
2	Fatigue 03/2021 - 05/2020
2	Gout 01/2021 - 01/2019
2	Chronic Pain 01/2020 - 01/2018
2	Systemic Scleroderma (Systemic Sclerosis) 01/2020 - 01/2016
2	Axial Spondyloarthritis 09/2019 - 05/2017
2	Dyspnea (Shortness of Breath) 09/2019 - 01/2016
2	Ankylosing Spondylitis 09/2019 - 11/2018
2	Joint Diseases (Joint Disease) 11/2018 - 11/2016
1	Psoriatic Arthritis 01/2024
1	Low Back Pain (Lumbago) 10/2023
1	Hyperalgesia 10/2023
1	Wounds and Injuries (Trauma) 04/2023
1	Muscular Atrophy (Muscle Atrophy) 11/2022
1	Edema (Dropsy) 11/2022
1	Osteophyte 10/2022
1	Overactive Urinary Bladder (Overactive Bladder) 06/2022
1	Small Fiber Neuropathy 05/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2021
1	COVID-19 10/2020
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Non-Radiographic Axial Spondyloarthritis 09/2019
1	Sacroiliitis 09/2019
1	Obesity 08/2019
1	Overweight 08/2019
1	Fibrosis (Cirrhosis) 01/2016
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2016
1	Disease Progression 01/2016
1	Osteoarthritis 01/2015
1	Bursitis (Adhesive Capsulitis) 01/2015
1	Adenocarcinoma 01/2015
1	Crystal Arthropathies 01/2015
1	Chondrocalcinosis (Pseudogout) 01/2015
1	Chondrocalcinosis 2 11/2013

Drug/Important Bio-Agent (IBA)

6	propylene diquat (PDQ(+))IBA 06/2022 - 01/2019
6	ametantrone (HAQ)IBA 03/2021 - 01/2016
4	C-Reactive ProteinIBA 06/2022 - 11/2018
3	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 10/2022 - 11/2013
3	Janus Kinase InhibitorsIBA 10/2022 - 06/2022
3	Abatacept (Orencia)FDA Link 06/2022 - 08/2019
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2020 - 12/2015
2	Antirheumatic Agents (DMARD)IBA 01/2024 - 10/2022
2	Analgesics (Analgesic Drugs)IBA 06/2023 - 10/2020
2	Duloxetine Hydrochloride (Cymbalta)FDA Link 06/2023 - 06/2023
2	Indicators and Reagents (Reagents)IBA 04/2023 - 10/2020
2	Biomarkers (Surrogate Marker)IBA 11/2022 - 05/2021
2	Uric Acid (Urate)IBA 01/2021 - 01/2019
2	aminoalcoholphosphotransferase (AAPT)IBA 10/2020 - 10/2020
2	AntibodiesIBA 01/2020 - 01/2016
2	Carbon MonoxideIBA 09/2019 - 01/2016
2	Anti-Citrullinated Protein AntibodiesIBA 09/2019 - 04/2019
2	Adalimumab (Humira)FDA Link 07/2017 - 11/2016
1	Immunoglobulin G (IgG)IBA 04/2024
1	Oxycodone (Oxycontin)FDA LinkGeneric 10/2023
1	Opioid Analgesics (Opioids)IBA 10/2023
1	Acetylcarnitine (Alcar)IBA 06/2023
1	palmidrolIBA 06/2023
1	Pregabalin (Lyrica)FDA Link 06/2023
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2023
1	A-factor (Streptomyces)IBA 12/2021
1	Anesthetics (Anesthetic Agents)IBA 10/2020
1	SiliconesIBA 01/2020
1	RNA Polymerase IIIIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	anti-RNA-polymerase III autoantibodyIBA 01/2020
1	Tumor Necrosis Factor InhibitorsIBA 09/2019
1	Rheumatoid FactorIBA 09/2019
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 09/2019
1	CytokinesIBA 01/2018
1	galactosamine glucuronoglycan sulfateIBA 12/2017
1	Calcium PyrophosphateIBA 01/2015

Therapy/Procedure

7	Therapeutics 01/2024 - 12/2015
3	Biological Therapy 01/2024 - 12/2015
2	Polypharmacy 06/2021 - 05/2020
2	Drug Therapy (Chemotherapy) 06/2021 - 01/2020
1	Electroacupuncture 10/2023
1	Pain Management 10/2022
1	Injections 07/2021
1	Precision Medicine 01/2020
1	Exercise Therapy (Therapy, Exercise) 01/2020
1	Breast Implants (Breast Implant) 01/2020
1	Cardiopulmonary Resuscitation (CPR) 05/2017
1	Colectomy 01/2015